TG Therapeutics, Inc. (TGTX) Stock Price Today & Analysis
TGTX
Valuation
Market cap$5.01B
Price-to-sales ratio9.42
Price-to-book value8.25
Price-earnings ratio11.20
Return on Equity133.00%
Return on Sales0.22%
Return on Assets0.60%
PEG ratioN/A
Earnings Per Share
Earnings Per Share$3.07
Income Statement
Average volume2,428,752
EBITDA$115.05M
1 year high (52w)$46.48
1 year low (52w)$25.28
Dividend
Dividend yield0.00%
Solvency
Debt-to-equity ratioN/A
About TG Therapeutics, Inc.
TG Therapeutics Inc is a fully integrated, commercial-stage, biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases. The company has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS). In addition, it is developing TG-1701 (BTK inhibitor), Azer-Cel (allogeneic CD19 CAR T), and TG-1801 (anti-CD47/CD19 bispecific mAb) for B-cell disorders, which are under Phase 1 trials. Geographically, the company generates a majority of its revenue selling BRIUMVI in the United States, with the rest coming from sales in other countries.
FAQ
You can easily purchase TG Therapeutics, Inc. (TGTX) shares through the Gotrade app. Simply download the app, set up your account, fund it, and then search for the 'TGTX' ticker to begin your investment journey.
At Gotrade, you can kickstart your investment in TG Therapeutics, Inc. with as little as $1.
Absolutely. Brokerage services on Gotrade Indonesia are provided by PT Valbury Asia Futures, a licensed futures and commodities broker registered with and supervised by the Indonesian Financial Services Authority (OJK).
Yes. Gotrade provides access to U.S. stocks from Indonesia through fully backed shares. This is facilitated through a cross-border order routing scheme for foreign stock derivative contracts (PALN), in accordance with regulations from Bappebti (the Commodity Futures Trading Regulatory Agency).
When you trade, you enter into a contract with PT Valbury Asia Futures (Valbury), a Bappebti-registered broker in Indonesia. Valbury, in turn, fully backs its contracts 1-for-1 with Alpaca Securities LLC, a FINRA-licensed broker-dealer in the United States. For every share (or fraction thereof) you hold on Gotrade, a corresponding share is held by Valbury in a separate, segregated brokerage account at Alpaca Securities LLC.
